Shalina Laboratories Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Shalina Laboratories Private Limited Pharmaceutical Export Portfolio Dataset — 6 Products, $6.2M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Shalina Laboratories Private Limited — Pharmaceutical Exporter Profile (2026) | 6 Products, $6.2M Trade | TransData Nexus

Shalina Laboratories Private Limited

Indian Pharmaceutical Exporter · Ayurvedic & Herbal Products Specialist · $6.2M Total Trade · DGFT Verified

Shalina Laboratories Private Limited is an Indian pharmaceutical exporter with a total trade value of $6.2M across 6 products in 4 therapeutic categories. Based on 523 verified export shipments from Indian Customs (DGFT) records, Shalina Laboratories Private Limited is the #1 Indian exporter in 1 product including Natural. Top exports include Natural ($4.5M), Pyrimethamine ($745.0K), Sulfadoxine ($745.0K).

Shalina Laboratories Private Limited — Export Portfolio & Destination Treemap

Shalina Laboratories Private Limited pharmaceutical export portfolio — 6 products across 4 therapeutic categories. Source: Indian Customs (DGFT).

Who is Shalina Laboratories Private Limited? — Company Overview & Market Position

Shalina Laboratories Private Limited, established on December 13, 1984, is a privately held pharmaceutical company headquartered in Mumbai, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U24239MH1984PTC034786. As of the latest available data, Shalina Laboratories has an authorized capital of ₹8.40 crore and a paid-up capital of ₹8.38 crore. The company employs approximately 314 professionals. Its registered office is located at 96 Maker Chamber V, Nariman Point, Mumbai, Maharashtra, 400021.

What Does Shalina Laboratories Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Natural$4.5M 2Pyrimethamine$745.0K 3

Product Portfolio — Top 6 by Export Value

Shalina Laboratories Private Limited exports 6 pharmaceutical products across 4 therapeutic categories. Market leader (#1 exporter) in 1 products.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Natural	Ayurvedic & Herbal Products	$4.5M	425	17.4%	1
2	Pyrimethamine	Antimalarial & Antiparasitic	$745.0K	43	1.2%	9
3	Sulfadoxine	Antimalarial & Antiparasitic	$745.0K	43	1.1%	7
4	Diazepam	CNS & Psychiatric	$124.6K	5	1.7%	10
5	Ibuprofen Paracetamol	Combination Drugs	$73.7K	4	3.8%	4
6	Paracetamol Caffeine	Combination Drugs	$73.6K	3	5.3%	4

Shalina Laboratories Private Limited exports 6 pharmaceutical products across 4 therapeutic categories with a total export value of $6.2M. The company is the #1 Indian exporter in 1 product: Natural. The top category is Ayurvedic & Herbal Products (71.6% of portfolio), followed by Antimalarial & Antiparasitic (24.0%), indicating a concentrated portfolio with the top 5 products accounting for 98.8% of total export value.

Shalina Laboratories Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Shalina Laboratories operates manufacturing facilities in India, specializing in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company exports a diverse portfolio of six products across four therapeutic categories, with a significant focus on Ayurvedic and herbal products. Specific details regarding the locations and capacities of these manufacturing plants are not publicly disclosed.

3Key Leadership

The leadership team at Shalina Laboratories includes:

Sundar Sankaran: Director since March 12, 2011.
Neelam Virji: Director since May 30, 2006.
Shalina Clifford: Director since February 10, 2015.
Fazle Abbas Virji: Director since February 10, 2015.
Sushil Kumar Agarwal: Company Secretary since April 1, 2013.

These individuals play pivotal roles in steering the company's strategic direction and operations.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Shalina Laboratories Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Shalina Laboratories has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has undertaken regulatory filings and approvals to access these markets, focusing on compliance with international standards. Specific details regarding the number of approved Abbreviated New Drug Applications (ANDAs), Drug Master Files (DMFs), and inspection histories are not publicly disclosed. The company's export data indicates a diversified product portfolio, with significant exports in the Ayurvedic and herbal products category, suggesting a strategic focus on markets with a demand for such products.

2Emerging Markets

Shalina Laboratories has expanded its footprint into emerging markets, particularly in Africa, Latin America, and Southeast Asia. The company's export data highlights a substantial market share in the Ayurvedic and herbal products category, which aligns with the growing demand for natural and traditional medicines in these regions. While specific details regarding WHO prequalification are not publicly available, the company's export activities suggest a strategic approach to penetrating these markets.

3Geographic Strategy

Shalina Laboratories Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Shalina Laboratories' FDA facility registrations, approved ANDAs, DMF filings, and inspection history are not publicly disclosed. The company's export data suggests a focus on markets with a demand for Ayurvedic and herbal products, which may influence its regulatory strategies in the United States.

2WHO & EU GMP

While specific information regarding WHO prequalification and EU Good Manufacturing Practice (GMP) certifications is not publicly available, the company's export activities to regulated markets imply adherence to international quality standards. The significant export value in Ayurvedic and herbal products suggests a strategic focus on markets with a demand for such products, which may require compliance with specific regulatory standards.

3CDSCO & Indian Regulatory

Shalina Laboratories holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO) and has approvals from state drug controllers. The company has obtained export No Objection Certificates (NOCs) from the Directorate General of Foreign Trade (DGFT), facilitating its international trade activities. Specific details regarding the number of manufacturing licenses, state approvals, and export NOCs are not publicly disclosed.

Shalina Laboratories Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Shalina Laboratories operates in a competitive landscape with several key players in the pharmaceutical industry, particularly in the Ayurvedic and herbal products segment. While specific market share comparisons and head-to-head analyses are not publicly available, the company's significant export value in this category indicates a strong position in the market. The focus on natural products aligns with the growing global demand for alternative and traditional medicines.

2Key Differentiators

Shalina Laboratories' key differentiators include its extensive experience in the pharmaceutical industry, a diversified product portfolio with a strong emphasis on Ayurvedic and herbal products, and a strategic focus on emerging markets with a demand for natural medicines. These strengths position the company to capitalize on global health trends favoring traditional and natural remedies.

3Strategic Position

Shalina Laboratories is strategically positioned in the generics and specialty pharmaceuticals sectors, with a particular emphasis on Ayurvedic and herbal products. The company's future outlook includes expanding its presence in emerging markets and enhancing its product offerings to meet the evolving needs of global consumers seeking natural and traditional medicines.

Buyer Due Diligence Brief — Evaluating Shalina Laboratories Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Shalina Laboratories has a track record of consistent export volume, with a total export value of $6.2 million USD and 523 shipments across six products in four therapeutic categories. The company's portfolio concentration, with the top five products accounting for 98.8% of exports, indicates a focused approach to product development and market penetration. The significant export value in Ayurvedic and herbal products suggests reliability and demand in this segment.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Registration: Confirm the facility's registration status with the U.S. Food and Drug Administration.
WHO-GMP Certification: Verify compliance with World Health Organization Good Manufacturing Practices.
EU GMP Certification: Ensure adherence to European Union Good Manufacturing Practices.

Frequently Asked Questions — Shalina Laboratories Private Limited

How many pharmaceutical products does Shalina Laboratories Private Limited export from India?

Shalina Laboratories Private Limited exports 6 pharmaceutical products across 4 therapeutic categories. The top exports are Natural ($4.5M), Pyrimethamine ($745.0K), Sulfadoxine ($745.0K), Diazepam ($124.6K), Ibuprofen Paracetamol ($73.7K). Total export value is $6.2M.

What is Shalina Laboratories Private Limited's total pharmaceutical export value?

Shalina Laboratories Private Limited's total pharmaceutical export value is $6.2M, based on 523 verified shipments recorded in Indian Customs (DGFT) data.

In which products is Shalina Laboratories Private Limited the #1 Indian exporter?

Shalina Laboratories Private Limited is the #1 Indian exporter in 1 products: Natural (17.4% market share).

What therapeutic categories does Shalina Laboratories Private Limited cover?

Shalina Laboratories Private Limited exports across 4 therapeutic categories. The largest are Ayurvedic & Herbal Products (71.6%, 1 products), Antimalarial & Antiparasitic (24.0%, 2 products), Combination Drugs (2.4%, 2 products).

Get Full Shalina Laboratories Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.